Expert Interview with Dr. Henrik Jungaberle
Prof. Dr. Thomas Metzinger (University of Mainz), Tura Patterson (Usona Institute), Dr. Henrik Jungaberle (MIND Foundation), and Prof. Dr. Gerhard Gründer (Central Institute of Mental Health Mannheim, University of Heidelberg) speak at the INSIGHT 2019 press conference.
Coming to terms with the past and the new research with psychedelic substances
A New Place for Psychedelic Substances in Psychotherapy and Psychiatry
For some years now, psychedelic substances have again been the subject of research at international universities. Psilocybin and the atypical psychedelic MDMA are quite close to achieving approval as drugs around the mid-2020s. At the same time, the psychedelic field suffers from a certain preponderance of the past: approaches from the 1960s and 1970s and indigenous and religious interpretive frameworks clash with neurobiological and modern psychotherapeutic understandings. At the same time, there are promising new developments such as the funding of depression research with psilocybin by the German Federal Ministry of Education and Research (BMBF).
At INSIGHT 2021, scientists and therapists, pharmaceutical industry and anthropology, philosophers, and chemists will come together to determine the potential place of LSD, psilocybin, DMT, MDMA, and other psychedelic substances in the treatment of mental disorders. In addition, we will discuss the use of non-pharmacological methods to alter and cultivate states of consciousness and all that it takes to build such unusual states of consciousness a legitimate and safe place in society. And, in 2021, we will again discuss the application of these substances and states for healthy people.
In a series of blog posts, INSIGHT 2021 creators are covering the basics of modern psychedelic culture, research, and conferences. Stay tuned and help the whole field develop the potentials of these substances and learn from the past.
… (more posts in the next weeks)
We look forward to welcoming you to Berlin in September! Sold out in 2019 – grab your ticket.
Die Bildergalerie zeigt Eindrücke von der INSIGHT 2019. Wir freuen uns, einerseits mit den wichtigsten Forschern und Therapeuten im psychedelischen Feld zu debattieren und andererseits auch massiv junge Wissenschaftler:innen zu fördern. Außerdem haben wir 2021 dafür gesorgt, dass Unternehmen und Vertreter staatlicher Behörden wie der BZgA eine Debatte über die Besonderheiten psychedelischer Therapie führen können.
September 9-12, 2021
INSIGHT is the biennial international conference of the MIND Foundation.
The MIND Foundation is a European, non-profit scientific and educational organization that promotes psychedelic research and therapy. Our work is based on the neurobiological and psychological potential of psychedelics to improve mental health and well-being in a clinical setting, for which the scientific base is continuously growing.
MIND is the opinion leader in Germany and Europe when it comes to psychedelic therapies and their scientific basis. We also relentlessly discuss the critical sides of this form of therapy and deal with guidelines and ethical foundations.